- Cirulli, Elizabeth T., Nicoletti, Paola, Abramson, Karen, Andrade, Raul J., Bjornsson, Einar S., Chalasani, Naga, Fontana, Robert J., Hallberg, Par, Li, Yi Ju, Lucena, M. Isabel, Long, Nanye, Molokhia, Mariam, Nelson, Matthew R., Odin, Joseph A., Pirmohamed, Munir, Rafnar, Thorunn, Serrano, Jose, Stefánsson, Kari, Stolz, Andrew, Martin, Jennifer H.
A pharmacological framework for integrating treating the host, drug repurposing and the damage response framework in COVID-19
A practical treatment for COVID-19 and the next pandemic
- Bhattacharya, Jahar, Booy, Robert, Kobzik, Lester, Leligdowicz, Aleksandra, Liao, James K., Martin, Jennifer H., Musher, Daniel M., Serhan, Charles N., Tashiro, Masato, Casadevall, Arturo, Dela Cruz, Charles, Fedson, David S., Garcia, Joe G. N., Grohmann, Gary, Hung, Ivan F. N., Jacobson, Jeffrey R., Jennings, Lance C.
Achieving the World Health Organization's vision for clinical pharmacology
- Nicoletti, Paola, Aithal, Guruprasad P., Carvajal, Alfonso, Cascorbi, Ingolf, Cirulli, Elizabeth T., Chalasani, Naga, Conforti, Anita, Coulthard, Sally A., Daly, Mark J., Day, Christopher P., Dillon, John F., Fontana, Robert J., Bjornsson, Einar S., Martin, Jennifer H., Andrade, Raul J., Sawle, Ashley, Arrese, Marco, Barnhart, Huiman X., Bondon-Guitton, Emmanuelle, Hayashi, Paul H., Bessone, Fernando
Barriers and challenges in performing pharmacokinetic atudies to inform sosing in the neonatal population
Communication, collaboration and care coordination: the three-point guide to cancer care provision for aboriginal and Torres Strait Islander Australians
Complementary and alternative therapies in the palliative setting
COVID infection in 4 steps: Thermodynamic considerations reveal how viral mucosal diffusion, target receptor affinity and furin cleavage act in concert to drive the nature and degree of infection in human COVID-19 disease
Are you sure you would like to clear your session, including search history and login status?